Unknown

Dataset Information

0

Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.


ABSTRACT: Vaccines, like drugs and medical procedures, are increasingly amenable to individualization or personalization, often based on novel data resulting from high throughput "omics" technologies. As a result of these technologies, 21st century vaccinology will increasingly see the abandonment of a "one size fits all" approach to vaccine dosing and delivery, as well as the abandonment of the empiric "isolate-inactivate-inject" paradigm for vaccine development. In this review, we discuss the immune response network theory and its application to the new field of vaccinomics and adversomics, and illustrate how vaccinomics can lead to new vaccine candidates, new understandings of how vaccines stimulate immune responses, new biomarkers for vaccine response, and facilitate the understanding of what genetic and other factors might be responsible for rare side effects due to vaccines. Perhaps most exciting will be the ability, at a systems biology level, to integrate increasingly complex high throughput data into descriptive and predictive equations for immune responses to vaccines. Herein, we discuss the above with a view toward the future of vaccinology.

SUBMITTER: Poland GA 

PROVIDER: S-EPMC3752773 | biostudies-other | 2013 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications

Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

Poland Gregory A GA   Kennedy Richard B RB   McKinney Brett A BA   Ovsyannikova Inna G IG   Lambert Nathaniel D ND   Jacobson Robert M RM   Oberg Ann L AL  

Seminars in immunology 20130401 2


Vaccines, like drugs and medical procedures, are increasingly amenable to individualization or personalization, often based on novel data resulting from high throughput "omics" technologies. As a result of these technologies, 21st century vaccinology will increasingly see the abandonment of a "one size fits all" approach to vaccine dosing and delivery, as well as the abandonment of the empiric "isolate-inactivate-inject" paradigm for vaccine development. In this review, we discuss the immune res  ...[more]

Similar Datasets

| S-EPMC5578455 | biostudies-literature
| S-EPMC7103233 | biostudies-literature
| S-EPMC7277910 | biostudies-literature
| S-EPMC1420684 | biostudies-literature
| S-EPMC3178397 | biostudies-literature
| S-EPMC3539946 | biostudies-literature
| S-EPMC8126645 | biostudies-literature
| S-EPMC2154407 | biostudies-literature
| S-EPMC6829555 | biostudies-literature
| S-EPMC6255148 | biostudies-literature